Margolis, Mathew S. MD; DeBusk, Adam A. DO; Moster, Mark L. MD; Falardeau, Julie M. MD; Eggenberger, Eric R. DO; Sergott, Robert C. MD; Van Stavern, Gregory P. MD
Editor(s): Fraser, Clare MD; Mollan, Susan MD
Department of Ophthalmology and Visual Sciences (MSM), Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, Illinois; Department of Ophthalmology and Visual Sciences (GVS), Washington University School of Medicine, St. Louis, Missouri; Department of Neuro-Ophthalmology (AD, MLM, RCS), Wills Eye Hospital; Department of Ophthalmology (JF), Oregon Health and Science University; and Department of Neurology (EE), Mayo Clinic, Jacksonville, Florida.
Address correspondence to Gregory Van Stavern, MD, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, 660 S. Euclid Avenue, St. Louis, MO 63110; E-mail: [email protected]
A. DeBusk: Research support: GenSight; M. L. Moster: Research support: GenSight and Regenera and speaker: Sanofi Genzyme.
The authors report no conflicts of interest.
doi: 10.1097/WNO.0000000000001319